OC
MD icon

Oppenheimer & Co’s Pediatrix Medical MD Stock Holding History

Oppenheimer & Co’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$321K Hold
12,654
– – ﹤0.01% 1451
2026
Q1 		$271K Sell
12,654
-500
-4% -$10.4K ﹤0.01% 1439
2025
Q4 		$281K Hold
13,154
– – ﹤0.01% 1291
2025
Q3 		$220K Sell
13,154
-3,500
-21% -$52.5K ﹤0.01% 1504
2025
Q2 		$239K Sell
16,654
-1,996
-11% -$27.4K ﹤0.01% 1434
2025
Q1 		$270K Sell
18,650
-1,650
-8% -$23.4K ﹤0.01% 1324
2024
Q4 		$266K Sell
20,300
-300
-1% -$4.14K ﹤0.01% 1330
2024
Q3 		$239K Sell
20,600
-500
-2% -$4.71K ﹤0.01% 1336
2024
Q2 		$159K Sell
21,100
-7,825
-27% -$64.7K ﹤0.01% 1363
2024
Q1 		$290K Sell
28,925
-8,000
-22% -$74.4K ﹤0.01% 1196
2023
Q4 		$343K Sell
36,925
-9,744
-21% -$101K 0.01% 1096
2023
Q3 		$593K Sell
46,669
-10,950
-19% -$150K 0.01% 874
2023
Q2 		$819K Sell
57,619
-15,738
-21% -$221K 0.02% 779
2023
Q1 		$1.09M Sell
73,357
-2,612
-3% -$39.6K 0.02% 658
2022
Q4 		$1.13M Sell
75,969
-9,870
-11% -$161K 0.03% 630
2022
Q3 		$1.42M Buy
85,839
+114
+0.1% +$2.29K 0.03% 535
2022
Q2 		$1.8M Sell
85,725
-2,093
-2% -$42.7K 0.04% 495
2022
Q1 		$2.06M Sell
87,818
-4,190
-5% -$103K 0.04% 494
2021
Q4 		$2.5M Sell
92,008
-479
-0.5% -$12.8K 0.04% 443
2021
Q3 		$2.63M Hold
92,487
– – 0.05% 426
2021
Q2 		$2.79M Buy
92,487
+26,908
+41% +$794K 0.05% 411
2021
Q1 		$1.67M Buy
+65,579
New +$1.68M 0.03% 521
2014
Q3 		– Sell
-6,939
Closed -$404K – 1464
2014
Q2 		$404K Sell
6,939
-17
-0.2% -$1K 0.01% 928
2014
Q1 		$431K Buy
+6,956
New +$405K 0.01% 882

Other funds holding MD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Oppenheimer & Co's MD Position: Q2 2026 in Review

Oppenheimer & Co held its Pediatrix Medical (MD) position steady in Q2 2026 at 12,654 shares worth $321K. The position accounts for ﹤0.01% of the portfolio, ranked #1451.

Oppenheimer & Co first reported a position in MD in Q1 2014 and has held it in 24 quarters since. The position peaked at $2.79M in Q2 2021. 305 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Oppenheimer & Co held 12,654 shares of Pediatrix Medical worth $321K as of Q2 2026.
  • Oppenheimer & Co left its Pediatrix Medical share count unchanged in Q2 2026.
  • Pediatrix Medical made up ﹤0.01% of Oppenheimer & Co's portfolio in Q2 2026, its #1451 holding.
  • Oppenheimer & Co first reported a position in Pediatrix Medical in Q1 2014 and has held it in 24 quarters since.
  • Oppenheimer & Co's Pediatrix Medical position peaked at $2.79M in Q2 2021.
  • 305 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.